These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 14568410

  • 21. Polymer source affects in vitro-in vivo correlation of leuprolide acetate PLGA microspheres.
    Wan B, Bao Q, Wang R, Burgess DJ.
    Int J Pharm; 2022 Sep 25; 625():122032. PubMed ID: 35878870
    [Abstract] [Full Text] [Related]

  • 22. Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying.
    Shi NQ, Zhou J, Walker J, Li L, Hong JKY, Olsen KF, Tang J, Ackermann R, Wang Y, Qin B, Schwendeman A, Schwendeman SP.
    J Control Release; 2020 May 10; 321():756-772. PubMed ID: 31935481
    [Abstract] [Full Text] [Related]

  • 23. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
    Oh JE, Nam YS, Lee KH, Park TG.
    J Control Release; 1999 Feb 22; 57(3):269-80. PubMed ID: 9895414
    [Abstract] [Full Text] [Related]

  • 24. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip.
    Grayson AC, Voskerician G, Lynn A, Anderson JM, Cima MJ, Langer R.
    J Biomater Sci Polym Ed; 2004 Feb 22; 15(10):1281-304. PubMed ID: 15559850
    [Abstract] [Full Text] [Related]

  • 25. A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process.
    Alcalá-Alcalá S, Urbán-Morlán Z, Aguilar-Rosas I, Quintanar-Guerrero D.
    Int J Nanomedicine; 2013 Feb 22; 8():2141-51. PubMed ID: 23788833
    [Abstract] [Full Text] [Related]

  • 26. Controlling degradation of acid-hydrolyzable pluronic hydrogels by physical entrapment of poly(lactic acid-co-glycolic acid) microspheres.
    Lee JB, Chun KW, Yoon JJ, Park TG.
    Macromol Biosci; 2004 Oct 20; 4(10):957-62. PubMed ID: 15487026
    [Abstract] [Full Text] [Related]

  • 27. Effect of stabilizers on bioactivity of peptide-24 in PLGA microspheres.
    Wang M, Guo X, Tan R, She Z, Feng Q.
    Med Chem; 2013 Dec 20; 9(8):1123-8. PubMed ID: 23227911
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
    Lim SM, Eom HN, Jiang HH, Sohn M, Lee KC.
    J Pharm Sci; 2015 Jan 20; 104(1):72-80. PubMed ID: 25407390
    [Abstract] [Full Text] [Related]

  • 32. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres.
    Fu K, Pack DW, Klibanov AM, Langer R.
    Pharm Res; 2000 Jan 20; 17(1):100-6. PubMed ID: 10714616
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A short term quality control tool for biodegradable microspheres.
    D'Souza S, Faraj JA, Dorati R, DeLuca PP.
    AAPS PharmSciTech; 2014 Jun 20; 15(3):530-41. PubMed ID: 24519488
    [Abstract] [Full Text] [Related]

  • 35. Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation.
    Hirota K, Doty AC, Ackermann R, Zhou J, Olsen KF, Feng MR, Wang Y, Choi S, Qu W, Schwendeman AS, Schwendeman SP.
    J Control Release; 2016 Dec 28; 244(Pt B):302-313. PubMed ID: 27565212
    [Abstract] [Full Text] [Related]

  • 36. A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery.
    Li JK, Wang N, Wu XS.
    J Pharm Sci; 1997 Aug 28; 86(8):891-5. PubMed ID: 9269865
    [Abstract] [Full Text] [Related]

  • 37. Impurity formation studies with peptide-loaded polymeric microspheres Part II. In vitro evaluation.
    Murty SB, Na DH, Thanoo BC, DeLuca PP.
    Int J Pharm; 2005 Jun 13; 297(1-2):62-72. PubMed ID: 15885939
    [Abstract] [Full Text] [Related]

  • 38. Stabilization of vinca alkaloids encapsulated in poly(lactide-co-glycolide) microspheres.
    Marinina J, Shenderova A, Mallery SR, Schwendeman SP.
    Pharm Res; 2000 Jun 13; 17(6):677-83. PubMed ID: 10955840
    [Abstract] [Full Text] [Related]

  • 39. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.
    Zhou J, Walker J, Ackermann R, Olsen K, Hong JKY, Wang Y, Schwendeman SP.
    Mol Pharm; 2020 May 04; 17(5):1502-1515. PubMed ID: 32074448
    [Abstract] [Full Text] [Related]

  • 40. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
    Woo BH, Jiang G, Jo YW, DeLuca PP.
    Pharm Res; 2001 Nov 04; 18(11):1600-6. PubMed ID: 11758769
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.